ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALB Albemarle Corporation

131.51
1.89 (1.46%)
After Hours
Last Updated: 21:18:04
Delayed by 15 minutes
Share Name Share Symbol Market Type
Albemarle Corporation NYSE:ALB NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  1.89 1.46% 131.51 134.29 130.47 130.87 1,546,072 21:18:04

Current Report Filing (8-k)

04/08/2015 9:10pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 3, 2015

 

 

ALBEMARLE CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Virginia   001-12658   54-1692118

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

451 Florida Street, Baton Rouge, Louisiana 70801

(Address of Principal Executive Offices, including Zip Code)

Registrant’s Telephone Number, including Area Code: (225) 388-8011

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 3, 2015, Albemarle Corporation (the “Company”) accepted the resignation of D. Michael Wilson, the Company’s Executive Vice President and President of Performance Chemicals, effective August 31, 2015. Luther Kissam IV, Chief Executive Officer and President of the Company, will assume the responsibilities of President of Performance Chemicals on an interim basis, while the Company conducts an internal and external search and until a permanent replacement for Mr. Wilson is named.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    ALBEMARLE CORPORATION
Date: August 4, 2015     By:  

/s/ Karen G. Narwold

      Name:   Karen G. Narwold
      Title:   Senior Vice President, General Counsel, Corporate & Government Affairs, Corporate Secretary

1 Year Albemarle Chart

1 Year Albemarle Chart

1 Month Albemarle Chart

1 Month Albemarle Chart

Your Recent History

Delayed Upgrade Clock